ESR1 and breast cancer: Considering the use of VA, as promising anticancer agent, we further focused our attention on signaling pathways mainly involved in breast cancer cells viability, using ER-α positive MCF-7 and triple negative (ER-α, PR, HER2) MDA-MB-231 cells.